SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-342745
Filing Date
2017-11-14
Accepted
2017-11-14 17:20:55
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d462205d10q.htm 10-Q 359366
2 EX-31.1 d462205dex311.htm EX-31.1 10175
3 EX-31.2 d462205dex312.htm EX-31.2 10025
4 EX-32.1 d462205dex321.htm EX-32.1 3568
5 EX-32.2 d462205dex322.htm EX-32.2 3541
12 GRAPHIC g462205g1113125353891.jpg GRAPHIC 2417
  Complete submission text file 0001193125-17-342745.txt   2503441

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ocrx-20170930.xml EX-101.INS 391031
7 XBRL TAXONOMY EXTENSION SCHEMA ocrx-20170930.xsd EX-101.SCH 31953
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocrx-20170930_cal.xml EX-101.CAL 46112
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocrx-20170930_def.xml EX-101.DEF 120360
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocrx-20170930_lab.xml EX-101.LAB 283808
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocrx-20170930_pre.xml EX-101.PRE 197527
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 171203036
SIC: 2834 Pharmaceutical Preparations